» Articles » PMID: 17299097

Prognostic Nomogram and Index for Overall Survival in Previously Untreated Patients with Chronic Lymphocytic Leukemia

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2007 Feb 15
PMID 17299097
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical course for patients with chronic lymphocytic leukemia is extremely heterogeneous. The Rai and Binet staging systems have been used to risk-stratify patients; most patients present with early-stage disease. We evaluated a group of previously untreated patients with chronic lymphocytic leukemia (CLL) at initial presentation to University of Texas M. D. Anderson Cancer Center to identify independent characteristics that predict for overall survival. Clinical and routine laboratory characteristics for 1674 previously untreated patients who presented for evaluation of CLL from 1981 to 2004 were included. Univariate and multivariate analyses identified several patient characteristics at presentation that predicted for overall survival in previously untreated patients with CLL. A multivariate Cox proportional hazards model was developed, including the following independent characteristics: age, beta-2 microglobulin, absolute lymphocyte count, sex, Rai stage, and number of involved lymph node groups. Inclusion of patients from a single institution and the proportion of patients younger than 65 years may limit this model. A weighted prognostic model, or nomogram, predictive for overall survival was constructed using these 6 characteristics for 5- and 10-year survival probability and estimated median survival time. This prognostic model may help patients and clinicians in clinical decision making as well as in clinical research and clinical trial design.

Citing Articles

Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.

Hallek M Am J Hematol. 2025; 100(3):450-480.

PMID: 39871707 PMC: 11803567. DOI: 10.1002/ajh.27546.


Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis.

Gonsalves M, Escobar A, Altarabishi A, Xu C Curr Issues Mol Biol. 2024; 46(8):8053-8070.

PMID: 39194693 PMC: 11352968. DOI: 10.3390/cimb46080476.


Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment.

Zhang Y, Yao X, Zhang Y, Chen Z, Qin Z, Cai Y Blood Lymphat Cancer. 2024; 14:49-62.

PMID: 38974337 PMC: 11227335. DOI: 10.2147/BLCTT.S468836.


Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator in patients undergoing peritoneal dialysis: a propensity score matching analysis.

Xia W, Hua X, Sun D, Xie X, Hu H Front Med (Lausanne). 2024; 11:1302603.

PMID: 38698782 PMC: 11063294. DOI: 10.3389/fmed.2024.1302603.


Predicting survival in patients with buccal cancer: A study based on SEER database and external validation in China.

Tan Y, Huang G, Hu J, Zhao S, Li Y, Wen Z Cancer Med. 2024; 13(3):e6907.

PMID: 38284829 PMC: 10905535. DOI: 10.1002/cam4.6907.